• Citer

PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.

par Marmolino, Daniele ;Acquaviva, Fabio;Pinelli, Michele;Monticelli, Antonella;Castaldo, Imma;Filla, Alessandro;Cocozza, Sergio
Référence Cerebellum, 8, 2, page (98-103)
Publication Publié, 2009-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.
Auteur:	Marmolino, Daniele; Acquaviva, Fabio; Pinelli, Michele; Monticelli, Antonella; Castaldo, Imma; Filla, Alessandro; Cocozza, Sergio
Informations sur la publication:	Cerebellum, 8, 2, page (98-103)
Statut de publication:	Publié, 2009-06
Sujet CREF:	Neurologie
	Sciences bio-médicales et agricoles
MeSH keywords:	Cell Line, Tumor
	Cells, Cultured
	Cerebellum -- drug effects -- metabolism -- physiopathology
	Fibroblasts -- drug effects -- metabolism
	Friedreich Ataxia -- drug therapy -- genetics -- metabolism
	Humans
	Hypoglycemic Agents -- pharmacology
	Iron-Binding Proteins -- drug effects -- genetics -- metabolism
	PPAR gamma -- agonists
	Phosphorylcholine -- analogs & derivatives -- pharmacology -- therapeutic use
	RNA, Messenger -- drug effects
	Thiazolidinediones -- pharmacology
	Transcriptional Activation -- drug effects -- genetics
	Up-Regulation -- drug effects -- genetics
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1473-4222
	info:doi/10.1007/s12311-008-0087-z
	info:pmid/19104905